NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with ...

Nex, maker of Nex Playground, the active play system that gets families moving together, has entered a licensing partnership ...

Events during the second quarter 2026 Eisai provided a sales forecast for Leqembi for the company's fiscal year 2026 (April 2026 to March ...

Critical Path Institute® (C-Path) today announced the publication of "Regulatory endorsement for the application of ...

AFI Labs offers a single collaborative environment where customers can rapidly develop, validate, and scale new food ...

The Silicon Valley-based power distribution manufacturer IEM plans to build a $200 million facility at Brooks and employ ...

A focus on teamwork and mutual support leads to better communication, fewer misunderstandings and more efficient teams.

The 33rd Pathways for Trade Symposium will bring industry leaders to TAMIU to discuss trade, infrastructure, manufacturing, ...

The new processor, called Jalapeño, outperformed Nvidia's GB300 in the amount of AI work completed per unit of power and the ...

Electric motor manufacturer says early collaboration between trailer makers and technology suppliers will be crucial to ...

ACCRA, GH / ACCESS Newswire / August 25, 2026 / Slangit Technologies and GADEF International have signed a five-year ...

Xanadu Quantum Technologies Limited (Toronto, Ont., Canada), a leading photonic quantum computing company, has announced the ...